Large Guardant Health study backs use of "liquid biopsies"

CHICAGO, June 4 (Reuters) - A large study sponsored by

privately held Guardant Health Inc of California showed that its

Guardant360 liquid biopsy test, which looks at bits of tumor DNA

in blood samples, closely mirrored the cancer genes taken from

traditional tissue biopsies.

Read more